Related Subjects:
|Sideroblastic Anaemia
|Splenectomy
|Paroxysmal Nocturnal Haemoglobinuria
|Pernicious anaemia
|Normocytic anaemiaa
|Pyruvate Kinase deficiency
|Blood Products - Platelets
|Von Willebrand Disease
About Haemolytic Disease of the Newborn
- A condition caused by haemolysis within the fetus due to the passage of maternal antibodies against the Rhesus (Rh) antigen.
- Occasionally seen due to incompatibilities between less common fetal and maternal blood group antigens, though Rhesus incompatibility is the most common cause.
Aetiology
- Occurs in Rhesus-negative mothers previously exposed to Rh-positive blood, leading to antibody formation. Exposure can happen during a prior pregnancy with an Rh-positive fetus or through transfusion of Rh-positive blood.
- Upon re-exposure, such as in a subsequent pregnancy with an Rh-positive fetus, maternal antibodies cross the placenta and cause fetal haemolysis.
Clinical Features
- Jaundice: Typically occurs soon after birth due to elevated bilirubin from RBC breakdown.
- Severe Hyperbilirubinaemia: Excessive bilirubin levels can lead to neurological complications.
- Severe Anaemia: Results from the destruction of fetal RBCs.
- Kernicterus: Severe neurological damage due to bilirubin accumulation in the brain.
- Hydrops Fetalis: Severe form leading to fetal death, characterized by generalized edema.
Investigations
- Blood Type Testing: Determine if the fetus is Rhesus-positive, placing an Rh-negative mother at risk.
- Coombs Test (Direct Antiglobulin Test): Positive test indicates antibody-coated RBCs in the fetus.
- Red Blood Cell Count: Decreased RBC count due to haemolysis.
- Reticulocytosis: Elevated immature RBCs as the body attempts to compensate for anaemia.
- Macrocytosis: Larger RBCs seen due to increased reticulocytes.
- Polychromasia: Presence of RBCs of varying colors indicating reticulocytosis and active haemolysis.
- Microspherocytosis: Small, spherical RBCs, a hallmark of haemolytic anaemia.
Management
- Transfusion: May be necessary in severe cases to correct anaemia.
- Hydration: Helps support circulation and bilirubin clearance.
- Phototherapy: A safe and effective treatment for reducing bilirubin levels by converting it to a form excretable by the body.
- Exchange Transfusion: In severe cases, exchange transfusion can remove bilirubin and antibody-coated RBCs, reducing haemolysis and bilirubin levels.
Prevention
- Rhesus-negative mothers should receive Anti-D immunoglobulin (Anti-RhD) whenever there is a risk of fetal blood exposure (e.g., miscarriage, delivery, or procedures that may cause fetal-maternal blood mixing).
- Administer Anti-D following delivery to prevent maternal sensitization, reducing the risk of antibody response in future pregnancies.
Administering Anti-D immunoglobulin helps prevent maternal immune system activation against the Rhesus antigen in future pregnancies, thus reducing the risk of haemolytic disease in subsequent Rh-positive fetuses.